Pasithea Therapeutics: Funding, Investors & Team (Sep 2026)
Pasithea Therapeutics is a biotechnology organization that looks to tackle clinical issues like emotional wellness. The organization is driven by famous immunologists based at Stanford University and their scholarly exploration is going by a top mental scholastic at King's College London. The drawn out point is to make an interpretation of examination into center prepared drugs. Pasithea Therapeutics' auxiliary tasks center around laying out enemy of misery facilities and portable centers across the US and UK, utilizing prepared drug specialists to direct intravenous imbuements of ketamine. Pasithea has cooperated with two effective facilities (THE IV DOC and Zen Health) for guaranteed openness in areas across Los Angeles, New York City, and London.
Pasithea Therapeutics has raised $5.7M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Sep 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pasithea Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Pasithea Therapeutics Funding Rounds
Pasithea Therapeutics raised $680k in a Grant announced in Jul 2022.
2.2 years later, an undisclosed round of $5.0M was announced in Sep 2024.
Pasithea Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Pasithea Therapeutics Funding Compared to Other Biotechnology Startups
Pasithea Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pasithea Therapeutics in Biotechnology and Venice
Companies Similar to Pasithea Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Pasithea Therapeutics Funding FAQs
What does Pasithea Therapeutics do?
Pasithea Therapeutics is a biotechnology organization that looks to tackle clinical issues like emotional wellness. The organization is driven by famous immunologists based at Stanford University and their scholarly exploration is going by a top mental scholastic at King's College London. The drawn out point is to make an interpretation of examination into center prepared drugs. Pasithea Therapeutics' auxiliary tasks center around laying out enemy of misery facilities and portable centers across the US and UK, utilizing prepared drug specialists to direct intravenous imbuements of ketamine. Pasithea has cooperated with two effective facilities (THE IV DOC and Zen Health) for guaranteed openness in areas across Los Angeles, New York City, and London.
How much funding has Pasithea Therapeutics raised?
Pasithea Therapeutics has raised $5.7M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Sep 2024.
When did Pasithea Therapeutics last raise funding?
Pasithea Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Sep 2024.
Who founded Pasithea Therapeutics?
FundedIQ lists Tiago Reis Marques (Founder) at Pasithea Therapeutics.
Where is Pasithea Therapeutics headquartered?
Pasithea Therapeutics is based in Venice, California, United States.
How many employees does Pasithea Therapeutics have?
Pasithea Therapeutics is in the 1-10 employee band.
How does Pasithea Therapeutics' funding compare to other Biotechnology startups?
Pasithea Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Pasithea Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pasithea Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.